ComplianceQuest ConQuest 2025 Event Brief
ComplianceQuest held its second annual user conference (ConQuest 2025) in Clearwater, FL from 8-10 April 2025. This year’s theme was “Empowering Tomorrow – Modernize Product Innovation to Supply Chain with an AI-Embedded Platform.” The event brought together 165 industry leaders and partners who are actively reshaping how work gets done across the entire product lifecycle.
ComplianceQuest announced “The Middle Office”—a new operational layer designed to bridge innovation and execution with AI at its core. Positioned as a digital nerve center, the Middle Office bridges traditional front-office operations (like R&D and customer service) with back-office systems (such as ERP and finance). It’s where AI, quality, and operational excellence converge—making it the operational layer that turns insights into action.
ComplianceQuest also introduced Version 15 of their platform, with expanded Generative AI capabilities built to support everything from proactive risk identification to intelligent CAPA and audit automation. Presentations and discussions throughout the event emphasized how AI is no longer a bolt-on—it’s becoming the foundation of modern quality ecosystems.
Through keynotes, CQ University sessions, or the hallway conversations, one message came through loud and clear: AI isn’t just powering the future—it’s redefining how we reach it.
Customer Presentation by Flex Health Solutions: The Next Generation of Digital Quality
In his ConQuest 2025 Keynote Address, Garth Conrad, VP of Quality at Flex Health Solutions, presented his organization’s transformation of its quality ecosystem through digitalization and AI.
Image Source: ComplianceQuest
Flex’s “Our QMS” initiative is at the heart of this journey—a strategic move from on-premise systems to a cloud-native platform, unifying 30+ disparate quality systems into a single, global eQMS. This consolidation supports over 200,000 users across 100+ locations in multiple languages, handling over 1 million migrated documents and integrating both regulated and non-regulated processes.
The modernized system is designed around four core principles of digital quality.
To reduce the burden of customization, Flex shifted from traditional “build vs. buy” to AI-adaptable solutions that leverage Generative and Predictive AI. This includes everything from summarizing CAPA records to suggesting risk mitigation strategies in real-time.
Conrad emphasized that, “AI isn’t replacing quality engineers; it’s revolutionizing their toolkit. Imagine giving them AI that acts like a virtual co-pilot, constantly analyzing data, predicting deviations, and optimizing processes in real-time. It frees them from mountains of paperwork and repetitive tasks, allowing them to focus on high-level problem-solving, design improvements, and ensuring patient safety. We’re empowering our quality engineers to operate at a strategic level, driving innovation and building quality into every stage of the medical device lifecycle.”
Conrad described a digital dream team powered by AI: a writer that drafts training docs, a CAPA guru that checks effectiveness, a validation pro that preps your protocols, and even a virtual FDA investigator. You name the role, and in the future, AI can support it. It can summarize reports, flag risky patterns, rewrite procedures, or just explain something in plain language. Basically, it’s like having a dozen extra quality specialists in your back pocket, 24/7. Flex is turning compliance from a chore into a competitive advantage with speed, smarts, and scale. These tools can detect spikes in complaints, run root cause analyses, automate supplier notifications, and generate preventive insights via FMEA.
Flex’s evolving eQMS doesn’t just support compliance—it’s reshaping how quality gets done at scale.
“For quality engineers in the medical device world, the stakes are incredibly high. Our AI-powered eQMS provides them with the predictive insights and automated workflows they need to not just react to issues, but to proactively prevent them. It’s like equipping them with a sixth sense for quality. This technology allows them to move from being inspectors to being architects of quality, designing robust systems and processes that consistently deliver safe and effective medical devices. Ultimately, it’s about elevating the role of the quality engineer to be a true strategic partner in our mission,” explained Conrad.
In Brief
ConQuest 2025 focused on customer stories that encompassed practical strategies for operationalizing digital transformation across the quality and manufacturing ecosystem. The sessions moved beyond big-picture vision and focused on execution. Presenters explored how to manage complex requirements and design lifecycles seamlessly, turn data into decisions, and unlock hidden value in ComplianceQuest’s platform.
The AI in manufacturing panel brought together leaders from Flex, PwC, Deloitte, and others to share how predictive intelligence and agentic systems are set to shape what’s next. It was a day of real-world insights and next-gen applications designed to move digital quality from idea to impact.
At ConQuest 2023 (ComplianceQuest’s premiere user conference), ChatGPT had just hit the scene, and generative AI was the buzzword of the day. Fast forward two years, and the life sciences ecosystem has moved from experimentation to enterprise-scale integration. It’s remarkable how quickly the conversation has evolved—from prompts to platforms and intelligent assistants.
We will continue to provide updates on ComplianceQuest as they become available.
Axendia Related Content:
- The Evolution of AI in Quality Management
- ConQuest 2023
- The State of Generative AI In Life Sciences: New Market Research
Ready to unlock new opportunities and drive success? Schedule an Analyst Inquiry today to explore how the latest advancements in automation, AI, and industrial autonomy can transform your business.
Visit Axendia.com or follow us on LinkedIn for more insights and updates. Together, we’ll prepare your organization for a future of resilience, adaptability, and growth.
The opinions and analysis expressed in this post reflect the judgment of Axendia at the time of publication and are subject to change without notice. Information contained in this post is current as of publication date. Information cited is not warranted by Axendia but has been obtained through a valid research methodology. This post is not intended to endorse any company or product and should not be attributed as such.